Mr. Speaker, the veterans affairs committee has heard personal testimony from veterans about the impact of the anti-malarial drug mefloquine. Many of our veterans have testified about suffering long-lasting and life-altering side effects after using this drug. In fact, after hearing these stories, the veterans affairs committee has unanimously agreed that action is needed. Why is the defence minister continuing to support the use of mefloquine, despite the mounting evidence of its harmful consequences?
In the House of Commons on November 21st, 2016. See this statement in context.